M E Lippman
Overview
Explore the profile of M E Lippman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
353
Citations
6900
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Speransky S, Serafini P, Caroli J, Bicciato S, Lippman M, Bishopric N
Breast Cancer Res Treat
. 2019 Apr;
176(2):271-289.
PMID: 31006104
Purpose: Primary breast and prostate cancers can be cured, but metastatic disease cannot. Identifying cell factors that predict metastatic potential could guide both prognosis and treatment. Methods: We used Cell-SELEX...
2.
Miller P, Kidwell K, Thomas D, Sabel M, Rae J, Hayes D, et al.
Breast Cancer Res Treat
. 2017 Jul;
166(1):85-94.
PMID: 28717852
Purpose: Elevated S100A8 expression has been observed in cancers of the bladder, esophagus, colon, ovary, and breast. S100A8 is expressed by breast cancer cells as well as by infiltrating immune...
3.
Kwak T, Drews-Elger K, Ergonul A, Miller P, Braley A, Hwang G, et al.
Oncogene
. 2016 Sep;
36(11):1559-1572.
PMID: 27669433
The receptor for advanced glycation end products (RAGE) is highly expressed in various cancers and is correlated with poorer outcome in breast and other cancers. Here we tested the role...
4.
Goka E, Lippman M
Oncogene
. 2015 Feb;
34(42):5395-405.
PMID: 25659579
The transition from ductal carcinoma in situ (DCIS) to invasive breast cancer (IBC) is a crucial step in breast cancer progression. The specific alterations that govern this transition have not...
5.
Dan T, Hewitt S, Ohri N, Ly D, Soule B, Smith S, et al.
Breast Cancer Res Treat
. 2013 Nov;
143(1):11-8.
PMID: 24276281
CD44 is a transmembrane glycoprotein involved in numerous cellular functions, including cell adhesion and extracellular matrix interactions. It is known to be functionally diverse, with alternative splice variants increasingly implicated...
6.
Hnatyszyn H, Liu M, Hilger A, Herbert L, Gomez-Fernandez C, Jorda M, et al.
Breast Cancer Res Treat
. 2009 Oct;
122(2):371-80.
PMID: 19842031
Studies of gene regulated by estrogen in breast cancer 1 (GREB1) have focused on mRNA levels with limited evidence about GREB1 protein expression in normal and breast cancer cells. A...
7.
8.
Rae J, Johnson M, Lippman M, Flockhart D
J Pharmacol Exp Ther
. 2001 Nov;
299(3):849-57.
PMID: 11714868
We used expression microarrays to test the effects of rifampin on the overall pattern of mRNA expression of multiple metabolic enzymes in primary human hepatocytes. Two microarrays were utilized, a...
9.
Yang X, Wei L, Tang C, Slack R, Mueller S, Lippman M
Cancer Res
. 2001 Jun;
61(13):5284-8.
PMID: 11431371
KAI1 is a metastasis suppressor gene for human prostate cancer and is also involved in the progression of a variety of other human cancers. Previously, we have demonstrated that KAI1...
10.
Lippman M, Krueger K, Eckert S, Sashegyi A, Walls E, Jamal S, et al.
J Clin Oncol
. 2001 Jun;
19(12):3111-6.
PMID: 11408508
Purpose: To test the hypothesis that risk factors related to lifetime estrogen exposure predict breast cancer incidence and to test if any subgroups experience enhanced benefit from raloxifene. Patients And...